TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H100. A total of 23 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,000 | – | 2,682 | +38214.3% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 7 | -99.7% | 0.00% | -100.0% |
| Q2 2017 | $5,000 | -44.4% | 2,171 | +23.0% | 0.00% | 0.0% |
| Q4 2016 | $9,000 | +50.0% | 1,765 | +73.2% | 0.00% | 0.0% |
| Q3 2016 | $6,000 | +200.0% | 1,019 | +92.3% | 0.00% | – |
| Q2 2016 | $2,000 | -85.7% | 530 | -73.8% | 0.00% | -100.0% |
| Q1 2016 | $14,000 | +7.7% | 2,020 | +51.4% | 0.00% | +100.0% |
| Q3 2015 | $13,000 | +1200.0% | 1,334 | +1234.0% | 0.00% | – |
| Q2 2015 | $1,000 | -95.7% | 100 | -93.9% | 0.00% | -100.0% |
| Q1 2015 | $23,000 | – | 1,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 995,000 | $3,134,000 | 0.33% |
| NEA Management Company, LLC | 2,759,217 | $8,692,000 | 0.30% |
| Eventide Asset Management | 900,000 | $2,835,000 | 0.16% |
| QVT Financial LP | 308,227 | $916,000 | 0.03% |
| Candriam S.C.A. | 143,000 | $450,000 | 0.01% |
| Virtu Financial LLC | 23,684 | $75,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,352 | $42,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 16,000 | $50,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 54,135 | $171,000 | 0.00% |
| Alyeska Investment Group, L.P. | 97,676 | $308,000 | 0.00% |